ULISSE BIOMED financial statements, including revenue, expenses, profit, and loss

The total revenue of UBM for the last semiannual is 370.86 k EUR, and it's 640.69% higher compared to the previous semiannual. The net income of H1 24 is -3.07 M EUR.